Oramed Pharmaceuticals (ORMP) Treasury Shares (2015 - 2025)

Oramed Pharmaceuticals has reported Treasury Shares for 11 years, with the latest figure at $4.4 million in Q4 2025.

• For the quarter ending Q4 2025, Treasury Shares rose 70.43% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (up 70.43% YoY), and the FY2025 full-year result was $4.4 million, up 70.43% from the prior year.
• Treasury Shares for Q4 2025 stood at $4.4 million, up from $3.1 million in the prior quarter.
• The five-year high for Treasury Shares was $4.5 million in Q2 2022, with the low at $118522.0 in Q2 2024.
• Historically, Treasury Shares has averaged $2.2 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2023 — Treasury Shares climbed 17.47% — and 2025, when it jumped 480.22%.
• Oramed Pharmaceuticals' Treasury Shares stood at $921302.0 in 2021, then jumped by 69.5% to $1.6 million in 2022, then gained by 17.47% to $1.8 million in 2023, then surged by 40.22% to $2.6 million in 2024, then soared by 70.43% to $4.4 million in 2025.
• The last three Treasury Shares figures came in at $4.4 million (Q4 2025), $3.1 million (Q3 2025), and $2.6 million (Q4 2024), per Business Quant data.